Filing Details

Accession Number:
0001193125-23-290989
Form Type:
13G Filing
Publication Date:
2023-12-07 19:00:00
Filed By:
Harraden Circle Investments, Llc
Company:
Aimei Health Technology Co. Ltd.
Filing Date:
2023-12-08
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Harraden Circle Investments 0 785,000 0 785,000 785,000 8.70%
Harraden Circle Investors GP 0 632,711 0 632,711 632,711 7.01%
Harraden Circle Investors GP 0 632,711 0 632,711 632,711 7.01%
Harraden Circle Investors 0 632,711 0 632,711 632,711 7.01%
Frederick V. Fortmiller, Jr 0 785,000 0 785,000 785,000 8.70%
Filing

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.    )*

 

 

Aimei Health Technology Co., Ltd

G01341117

(CUSIP Number)

December 1, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Continued on following pages

Page 1 of 11 Pages

Exhibit Index: 10 Page

 

 

 


CUSIP No. G01341117       Page 2 of 10 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Harraden Circle Investments, LLC

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5    

  SOLE VOTING POWER

 

  0

   6  

  SHARED VOTING POWER

 

  785,000

   7  

  SOLE DISPOSITIVE POWER

 

  0

   8  

  SHARED DISPOSITIVE POWER

 

  785,000

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  785,000

10  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  8.70%

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  OO, HC, IA


CUSIP No. G01341117       Page 3 of 10 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Harraden Circle Investors GP, LP

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5    

  SOLE VOTING POWER

 

  0

   6  

  SHARED VOTING POWER

 

  632,711

   7  

  SOLE DISPOSITIVE POWER

 

  0

   8  

  SHARED DISPOSITIVE POWER

 

  632,711

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  632,711

10  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  7.01%

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  PN, HC


CUSIP No. G01341117       Page 4 of 10 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Harraden Circle Investors GP, LLC

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5    

  SOLE VOTING POWER

 

  0

   6  

  SHARED VOTING POWER

 

  632,711

   7  

  SOLE DISPOSITIVE POWER

 

  0

   8  

  SHARED DISPOSITIVE POWER

 

  632,711

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  632,711

10  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  7.01%

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  OO, HC


CUSIP No. G01341117       Page 5 of 10 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Harraden Circle Investors, LP

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5    

  SOLE VOTING POWER

 

  0

   6  

  SHARED VOTING POWER

 

  632,711

   7  

  SOLE DISPOSITIVE POWER

 

  0

   8  

  SHARED DISPOSITIVE POWER

 

  632,711

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  632,711

10  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  7.01%

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  PN


CUSIP No. G01341117       Page 6 of 10 Pages

 

  1    

  NAMES OF REPORTING PERSONS

 

  Frederick V. Fortmiller, Jr.

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5    

  SOLE VOTING POWER

 

  0

   6  

  SHARED VOTING POWER

 

  785,000

   7  

  SOLE DISPOSITIVE POWER

 

  0

   8  

  SHARED DISPOSITIVE POWER

 

  785,000

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  785,000

10  

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  8.70%

12  

  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

  IN, HC


CUSIP No. G01341117       Page 7 of 10 Pages

 

Item 1(a).

Name of Issuer

Aimei Health Technology Co., Ltd (the issuer)

 

Item 1(b).

Address of Issuers Principal Executive Offices

10 East53rd Street, Suite 3001,New York, NY 10022

 

Item 2(a).

Names of Persons Filing

This Statement is filed on behalf of the following persons (collectively, the Reporting Persons):

 

  i)

Harraden Circle Investors, LP (Harraden Fund);

 

  ii)

Harraden Circle Investors GP, LP (Harraden GP);

 

  iii)

Harraden Circle Investors GP, LLC (Harraden LLC);

 

  iv)

Harraden Circle Investments, LLC (Harraden Adviser); and v) Frederick V. Fortmiller, Jr. (Mr. Fortmiller);

This Statement relates to Shares (as defined herein) directly beneficially owned by Harraden Fund. Harraden GP is the general partner to Harraden Fund, and Harraden LLC is the general partner of Harraden GP. Harraden Adviser serves as investment manager to Harraden Fund and other high net worth individuals. Mr. Fortmiller is the managing member of each of Harraden LLC and Harraden Adviser. In such capacities, each of Harraden GP, Harraden LLC, Harraden Adviser and Mr. Fortmiller may be deemed to indirectly beneficially own the Shares reported herein directly beneficially owned by Harraden Fund.

 

Item 2(b).

Address of Principal Business Office or, if None, Residence

The address of the principal business office of each Reporting Person is 299 Park Avenue, 21st Floor, New York, NY 10171.

 

Item 2(c).

Citizenship

Each of Harraden Fund and Harraden GP is a Delaware limited partnership. Each of Harraden LLC and Harraden Adviser is a Delaware limited liability company. Mr. Fortmiller is a citizen of the United States of America.

 

Item 2(d).

Title of Class of Securities

Class A Common Stock, par value $0.0001 per share (Shares)

 

Item 2(e).

CUSIP No. G01341117

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: This Item 3 is not applicable.


CUSIP No. G01341117       Page 8 of 10 Pages

 

Item 4.

Ownership

 

Item 4(a)

Amount Beneficially Owned

As of December 1, 2023, each of the Reporting Persons may be deemed the beneficial owner of 785,000 Shares underlying Units held directly by Harraden Fund and Harraden Adviser.

 

Item 4(b)

Percent of Class Fund and Harraden Adviser.

As of December 1, 2023, each of the Reporting Persons may be deemed the beneficial owner of approximately 8.70% of Shares outstanding. This percentage is based on a total of 9,026,000 Shares outstanding, based on information in the Form 8-K filed by the Company on December 7, 2023.

 

Item 4(c)

Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote:

     0  

(ii) Shared power to vote or direct the vote:

     785,000  

(iii) Sole power to dispose or direct the disposition of:

     0  

(iv) Shared power to dispose or direct the disposition of:

     785,000  

 

Item 5.

Ownership of Five Percent or Less of a Class

This Item 5 is not applicable.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

This Item 6 is not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

See disclosure in Item 2 hereof.

 

Item 8.

Identification and Classification of Members of the Group

This Item 8 is not applicable.

 

Item 9.

Notice of Dissolution of Group

This Item 9 is not applicable.

 

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


CUSIP No. G01341117       Page 9 of 10 Pages

 

SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: December 8, 2023

 

HARRADEN CIRCLE INVESTORS, LP
By:   HARRADEN CIRCLE INVESTORS GP, LP, its general partner
By:   HARRADEN CIRCLE INVESTORS GP, LLC, its general partner
By:   /s/ Frederick V. Fortmiller, Jr.
Title:   Managing Member
HARRADEN CIRCLE INVESTORS GP, LP
By:   HARRADEN CIRCLE INVESTORS GP, LLC, its general partner
By:   /s/ Frederick V. Fortmiller, Jr.
Title:   Managing Member
HARRADEN CIRCLE INVESTORS GP, LLC
By:   /s/ Frederick V. Fortmiller, Jr.
  Managing Member
HARRADEN CIRCLE INVESTMENTS, LLC By:
By:   /s/ Frederick V. Fortmiller, Jr.
  Managing Member
FREDERICK V. FORTMILLER, JR.
/s/ Frederick V. Fortmiller, Jr.

CUSIP No. G01341117       Page 10 of 10 Pages

 

Exhibit INDEX

 

Joint Filing Agreement    11